Fulgent Genetics, Inc. (FLGT) vs OPKO Health, Inc. (OPK)
- Fulgent Genetics, Inc. FLGT 19.81 −7.17%
- OPKO Health, Inc. OPK 1.53 −4.97%
Fulgent Genetics, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. OPKO Health, Inc. is the larger, with a market value of $1.2B against $587.2M — 2.0× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 6.83% against −11.5%. OPKO Health, Inc. has the higher net margin (−12.4% vs −26.1%) and the higher return on invested capital (−2.45% vs −10.3%). Across the 18 metrics below, OPKO Health, Inc. leads on 10 and Fulgent Genetics, Inc. on 8.
Valuation
Profitability
| Metric | FLGT | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 35.58% | 40.77% | 50.89% |
| Operating margin | (37.75%) | (8.21%) | (8.57%) |
| Net margin | (26.05%) | (12.40%) | (6.37%) |
| Free cash flow margin | (32.04%) | (22.75%) | 0.00% |
| Return on equity | (8.01%) | (5.88%) | (2.92%) |
| Return on assets | (7.37%) | (3.83%) | (6.71%) |
| Return on invested capital | (10.34%) | (2.45%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack